Limitation of Hepatitis B Markers in Cord Blood for Diagnosing Intrauterine Infection of Hepatitis B Virus

刘景丽,刘兰华,徐陈瑜,陈廷美,徐飚,陈洁,胡娅莉,周乙华

DOI: https://doi.org/10.3760/cma.j.issn.1007-9408.2015.11.004

2015-01-01

Abstract:Objective To investigate the role of hepatitis B virus (HBV) DNA and hepatitis B core antibody (anti-HBc) IgM in cord blood for diagnosis of HBV intrauterine infection.Methods From October 8, 2011 to May 31, 2013, a total of 278 pregnant women with positive hepatitis B surface antigen (HBsAg) were enrolled from Nanjing Drum Tower Hospital, Taixing People's Hospital, and Zhenjiang Metarnal and Child Hospital.None of them had received antiviral therapy, co-infection with hepatitis C virus or human immunodeficiency virus.All 281 newborns (three pairs of twins) of them had been vaccinated against hepatitis B and received hepatitis B immunoglobulin (HBIG) within 12 h after birth.Serum samples of HBsAg-positive women at 2 days after delivery and cord sera of their neonates as well as sera of these children followed up at the age of 7-12 months were collected.HBV DNA levels were detected by fluorescent quantitative polymerase chain reaction, with the lower detection limit of 102 U/ml.HBV serologic markers and anti-HBc IgM were examined by enzyme linked immunosorbent assay.HBsAg and hepatitis B e antigen (HBeAg) were quantified with Abbott reagents.Then we analyzed the rate of infants followed-up, the level of HBV markers, and the relationship of HBV DNA, anti-HBc IgM and HBV intrauterine infection.Results Totally 214 (76.2％) infants were followed up at the age of 7 12 months.Of the 71 cord blood samples of HBeAg-negative mothers, eight (11.3％) had detectable HBV DNA;among the 56 followed-up infants, seven (9.9％) were positive for HBV DNA, while 54 were positive for anti-HBs and negative for both HBsAg and anti-HBc.None of the above 56 infants were positive for HBsAg, HBeAg, or anti-HBc.Of the 210 cord blood samples of the 207 HBeAg-positive mothers, 86 (41.0％) had detectable HBV DNA.Of the 158 infants who attended the follow-up, 38 (24.1％, 38/158) were positive for both HBV DNA and HBsAg, while only six (3.8％, 6/158) were positive for HBsAg, HBeAg, and anti-HBc.Chronic HBV infection was diagnosed when levels of HBV DNA ranged from 1.55 × 107 to 1.51 × 109 U/ml.Seven infants with HBV DNA ≥ 105 U/ml in cord blood were followed up, and only three confirmed to be HBV infection.The other four cases were not infected and effectively protected.Of the three infected infants,one showed 9.18 × 103 U/ml HBV DNA level in cord blood, and the remaining two were below 102 U/ml.AntiHBc IgM was negative in all 281 cord blood.Conclusions The intrauterine infection can not be determined by high level of HBV DNA in cord blood, nor be ruled out by undetectability of HBV DNA.The positive rate of anti-HBc IgM in cord blood is extremely low, indicating the useless of anti-HBc IgM in cord blood to define intrauterine infection.